Wolf Group Capital Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$914K Sell
9,029
-1,914
-17% -$187K 0.31% 91
2024
Q4
$741K Hold
10,943
0.36% 73
2024
Q3
$741K Buy
10,943
+1,132
+12% +$102K 0.35% 74
2024
Q2
$842K Sell
9,811
-1,132
-10% -$95K 0.33% 81
2024
Q1
$741K Hold
10,943
0.35% 74
2023
Q4
$741K Buy
10,943
+703
+7% +$45.5K 0.35% 74
2023
Q3
$688K Sell
10,240
-683
-6% -$47K 0.33% 78
2023
Q2
$681K Sell
10,923
-1,033
-9% -$64.7K 0.34% 74
2023
Q1
$647K Sell
11,956
-1,769
-13% -$103K 0.32% 75
2022
Q4
$821K Sell
13,725
-433
-3% -$23.5K 0.39% 70
2022
Q3
$640K Sell
14,158
-3,644
-20% -$182K 0.35% 75
2022
Q2
$794K Sell
17,802
-631
-3% -$32.4K 0.41% 70
2022
Q1
$1.04M Sell
18,433
-37,627
-67% -$1.96M 0.53% 61
2021
Q4
$2.91M Buy
56,060
+38,203
+214% +$1.97M 0.48% 64
2021
Q3
$1.07M Sell
17,857
-122
-0.7% -$7.68K 0.58% 60
2021
Q2
$1.12M Buy
17,979
+329
+2% +$21.9K 0.6% 61
2021
Q1
$1.15M Buy
17,650
+183
+1% +$11.9K 0.66% 55
2020
Q4
$1.15M Sell
17,467
-162
-0.9% -$9.53K 0.71% 56
2020
Q3
$911K Buy
17,629
+50
+0.3% +$2.57K 0.63% 54
2020
Q2
$866K Sell
17,579
-642
-4% -$34.6K 0.65% 54
2020
Q1
$928K Sell
18,221
-41,437
-69% -$2.39M 0.77% 48
2019
Q4
$3.29M Buy
59,658
+9,364
+19% +$508K 2.16% 16
2019
Q3
$2.53M Buy
50,294
+1,794
+4% +$90.1K 1.74% 23
2019
Q2
$2.44M Sell
48,500
-1,188
-2% -$57.7K 1.69% 23
2019
Q1
$2.31M Buy
49,688
+4,681
+10% +$237K 1.59% 24
2018
Q4
$2.21M Buy
45,007
+259
+0.6% +$14.7K 1.64% 22
2018
Q3
$2.77M Sell
44,748
-1,916
-4% -$117K 1.81% 15
2018
Q2
$2.51M Sell
46,664
-301
-0.6% -$15K 1.64% 20
2018
Q1
$2.14M Buy
46,965
+1,732
+4% +$74.2K 1.41% 27
2017
Q4
$1.78M Buy
+45,233
New +$1.72M 1.11% 37

Other funds holding EHC

Wolf Group Capital Advisors's EHC Position: Q1 2025 in Review

Wolf Group Capital Advisors reduced its Encompass Health (EHC) stake by 17% in Q1 2025, selling an estimated $187K and leaving 9,029 shares worth $914K. The position accounts for 0.31% of the portfolio, ranked #91.

Wolf Group Capital Advisors first reported a position in EHC in Q4 2017 and has held it in 30 quarters since. The position peaked at $3.29M in Q4 2019. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

  • Wolf Group Capital Advisors held 9,029 shares of Encompass Health worth $914K as of Q1 2025.
  • Wolf Group Capital Advisors sold 1,914 Encompass Health shares in Q1 2025, an estimated $187K.
  • Encompass Health made up 0.31% of Wolf Group Capital Advisors's portfolio in Q1 2025, its #91 holding.
  • Wolf Group Capital Advisors first reported a position in Encompass Health in Q4 2017 and has held it in 30 quarters since.
  • Wolf Group Capital Advisors's Encompass Health position peaked at $3.29M in Q4 2019.
  • 537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Wolf Group Capital Advisors's 13F filing for Q1 2025, filed 18 Apr 2025.